{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:56:19Z","timestamp":1774353379236,"version":"3.50.1"},"reference-count":95,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>While first and foremost considered a respiratory infection, COVID-19 can result in complications affecting multiple organs. Immune responses in COVID-19 can both protect against the disease as well as drive it. Insights into these responses, and specifically the targets being recognised by the immune system, are of vital importance in understanding the side effects of COVID-19 and associated pathologies. The body\u2019s adaptive immunity recognises and responds against specific targets (antigens) expressed by foreign pathogens, but not usually to target self-antigens. However, if the immune system becomes dysfunctional, adaptive immune cells can react to self-antigens, which can result in autoimmune disease. Viral infections are well reported to be associated with, or exacerbate, autoimmune diseases such as multiple sclerosis (MS) and systemic lupus erythematosus (SLE). In COVID-19 patients, both new onset MS and SLE, as well as the occurrence of other autoimmune-like pathologies, have been reported. Additionally, the presence of autoantibodies, both with and without known associations to autoimmune diseases, have been found. Herein we describe the mechanisms of virally induced autoimmunity and summarise some of the emerging reports on the autoimmune-like diseases and autoreactivity that is reported to be associated with SARS-CoV-2 infection.<\/jats:p>","DOI":"10.3390\/ijms22168965","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T08:44:45Z","timestamp":1629449085000},"page":"8965","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Adaptive Immunity and the Risk of Autoreactivity in COVID-19"],"prefix":"10.3390","volume":"22","author":[{"given":"Rhiane","family":"Moody","sequence":"first","affiliation":[{"name":"School of Health and Biomedical Science, RMIT University, Bundoora, VIC 3083, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty","family":"Wilson","sequence":"additional","affiliation":[{"name":"School of Health and Biomedical Science, RMIT University, Bundoora, VIC 3083, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1575-1953","authenticated-orcid":false,"given":"Katie L.","family":"Flanagan","sequence":"additional","affiliation":[{"name":"School of Health and Biomedical Science, RMIT University, Bundoora, VIC 3083, Australia"},{"name":"Tasmanian Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, TAS 7250, Australia"},{"name":"School of Medicine, University of Tasmania, Launceston, TAS 7250, Australia"},{"name":"Department of Immunology and Pathology, Monash University, Melbourne, VIC 3004, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Jaworowski","sequence":"additional","affiliation":[{"name":"School of Health and Biomedical Science, RMIT University, Bundoora, VIC 3083, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6889-3667","authenticated-orcid":false,"given":"Magdalena","family":"Plebanski","sequence":"additional","affiliation":[{"name":"School of Health and Biomedical Science, RMIT University, Bundoora, VIC 3083, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"ref_1","unstructured":"WHO (2021, August 17). Who Coronavirus Disease (COVID-19) Dashboard. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"WHO (2020, October 10). Coronavirus Disease (COVID-19) Advice for the Public. Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/advice-for-public.","DOI":"10.46945\/bpj.10.1.03.01"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102581","DOI":"10.1016\/j.amjoto.2020.102581","article-title":"COVID-19 and anosmia: A review based on up-to-date knowledge","volume":"41","author":"Meng","year":"2020","journal-title":"Am. J. Otolaryngol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jmv.25809","article-title":"Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in wuhan, China","volume":"92","author":"Han","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e925753","DOI":"10.12659\/AJCR.925753","article-title":"Superior mesenteric artery thrombosis and acute intestinal ischemia as a consequence of COVID-19 infection","volume":"21","author":"Cheung","year":"2020","journal-title":"Am. J. Case Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbi.2020.06.020","article-title":"Spectrum of neuropsychiatric manifestations in COVID-19","volume":"88","author":"Nalleballe","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1148\/radiol.2020201187","article-title":"COVID-19\u2013associated acute hemorrhagic necrotizing encephalopathy: Imaging features","volume":"296","author":"Poyiadji","year":"2020","journal-title":"Radiology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1056\/NEJMc2009787","article-title":"Large-vessel stroke as a presenting feature of COVID-19 in the young","volume":"382","author":"Oxley","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_10","first-page":"2680160","article-title":"Fundamentals and methods for t- and b-cell epitope prediction","volume":"2017","author":"Reche","year":"2017","journal-title":"J. Immunol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Post, N., Eddy, D., Huntley, C., van Schalkwyk, M.C.I., Shrotri, M., Leeman, D., Rigby, S., Williams, S.V., Bermingham, W.H., and Kellam, P. (2021). Antibody response to sars-cov-2 infection in humans: A systematic review. PLoS ONE, 15.","DOI":"10.1101\/2020.08.25.20178806"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Shrotri, M., van Schalkwyk, M.C.I., Post, N., Eddy, D., Huntley, C., Leeman, D., Rigby, S., Williams, S.V., Bermingham, W.H., and Kellam, P. (2021). T cell response to sars-cov-2 infection in humans: A systematic review. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0245532"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41590-020-0773-7","article-title":"Orf8 and orf3b antibodies are accurate serological markers of early and late sars-cov-2 infection","volume":"21","author":"Hachim","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of t cell responses to sars-cov-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"a006957","DOI":"10.1101\/cshperspect.a006957","article-title":"T-cell tolerance: Central and peripheral","volume":"4","author":"Xing","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nri.2017.19","article-title":"Mechanisms of central tolerance for b cells","volume":"17","author":"Nemazee","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1126\/science.aaa1292","article-title":"Detection of self-reactive cd8(+) t cells with an anergic phenotype in healthy individuals","volume":"346","author":"Maeda","year":"2014","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.4049\/jimmunol.1500880","article-title":"The contained self-reactive peripheral t cell repertoire: Size, diversity, and cellular composition","volume":"195","author":"Richards","year":"2015","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.coi.2008.09.001","article-title":"B-cell tolerance checkpoints in health and autoimmunity","volume":"20","author":"Meffre","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/0008-5472.CAN-14-2538","article-title":"Cancer immunotherapy and breaking immune tolerance: New approaches to an old challenge","volume":"75","author":"Makkouk","year":"2015","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0952-7915(02)00406-5","article-title":"Making and breaking tolerance","volume":"14","author":"Ohashi","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1189\/jlb.1A0913-500RR","article-title":"Inflammation programs self-reactive cd8+ t cells to acquire t-box-mediated effector function but does not prevent deletional tolerance","volume":"96","author":"Jackson","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"i55","DOI":"10.1093\/rheumatology\/kew427","article-title":"Pathways leading to an immunological disease: Systemic lupus erythematosus","volume":"56","author":"Zharkova","year":"2017","journal-title":"Rheumatology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5493\/wjem.v4.i3.27","article-title":"Multiple sclerosis and the role of immune cells","volume":"4","author":"Maghazachi","year":"2014","journal-title":"World J. Exp. Med."},{"key":"ref_25","first-page":"501","article-title":"The mosaic of autoimmunity: The role of environmental factors","volume":"1","author":"Pereira","year":"2009","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Smatti, M.K., Cyprian, F.S., Nasrallah, G.K., Al Thani, A.A., Almishal, R.O., and Yassine, H.M. (2019). Viruses and autoimmunity: A review on the potential interaction and molecular mechanisms. Viruses, 11.","DOI":"10.3390\/v11080762"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.immuni.2007.09.002","article-title":"Antibodies and b cell memory in viral immunity","volume":"27","author":"Radbruch","year":"2007","journal-title":"Immunity"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.it.2017.04.002","article-title":"Mechanisms and dynamics of t cell-mediated cytotoxicity in vivo","volume":"38","author":"Halle","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2141.2009.07714.x","article-title":"Cytomegalovirus can make immune thrombocytopenic purpura refractory","volume":"146","author":"DiMaggio","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10067-015-2868-3","article-title":"Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods","volume":"34","author":"Chen","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"R295","DOI":"10.1186\/ar1181","article-title":"Patients with systemic lupus erythematosus have abnormally elevated epstein-barr virus load in blood","volume":"6","author":"Moon","year":"2004","journal-title":"Arthritis Res."},{"key":"ref_32","first-page":"1029","article-title":"High titer of antibody to the epstein-barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"16","author":"Yokochi","year":"1989","journal-title":"J. Rheumatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00125-016-4177-z","article-title":"Detection of enteroviruses in stools precedes islet autoimmunity by several months: Possible evidence for slowly operating mechanisms in virus-induced autoimmunity","volume":"60","author":"Honkanen","year":"2017","journal-title":"Diabetologia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1464-5491.2011.03529.x","article-title":"Type 1 diabetes and measles, mumps and rubella childhood infections within the italian insulin-dependent diabetes registry","volume":"29","author":"Ramondetti","year":"2012","journal-title":"Diabet. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/WNL.32.3.292","article-title":"Antibodies to coronaviruses oc43 and 229e in multiple sclerosis patients","volume":"32","author":"Salmi","year":"1982","journal-title":"Neurology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0042-6822(92)90220-J","article-title":"Human coronavirus gene expression in the brains of multiple sclerosis patients","volume":"191","author":"Stewart","year":"1992","journal-title":"Virology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1128\/JVI.74.19.8913-8921.2000","article-title":"Neuroinvasion by human respiratory coronaviruses","volume":"74","author":"Arbour","year":"2000","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ana.410390213","article-title":"Myelin basic protein and human coronavirus 229e cross-reactive t cells in multiple sclerosis","volume":"39","author":"Talbot","year":"1996","journal-title":"Ann. Neurol."},{"key":"ref_39","first-page":"001155","article-title":"Severe immune thrombocytopenia complicated by intracerebral haemorrhage associated with coronavirus infection: A case report and literature review","volume":"6","author":"Magdi","year":"2019","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/bmj.326.7403.1358","article-title":"Haematological manifestations in patients with severe acute respiratory syndrome: Retrospective analysis","volume":"326","author":"Wong","year":"2003","journal-title":"BMJ"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10245330400026170","article-title":"Thrombocytopenia in patients with severe acute respiratory syndrome (review)","volume":"10","author":"Yang","year":"2005","journal-title":"Hematology"},{"key":"ref_42","first-page":"304","article-title":"Cross-reaction of sars-cov antigen with autoantibodies in autoimmune diseases","volume":"1","author":"Wang","year":"2004","journal-title":"Cell Mol. Immunol"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/cts.12805","article-title":"Clinical and autoimmune characteristics of severe and critical cases of COVID-19","volume":"13","author":"Zhou","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/annrheumdis-2020-218009","article-title":"Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19","volume":"79","author":"Vlachoyiannopoulos","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type i ifns in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zuo, Y., Estes, S.K., Ali, R.A., Gandhi, A.A., Yalavarthi, S., Shi, H., Sule, G., Gockman, K., Madison, J.A., and Zuo, M. (2020). Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med., 12.","DOI":"10.1126\/scitranslmed.abd3876"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbi.2020.12.022","article-title":"High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms","volume":"93","author":"Franke","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s11239-020-02182-9","article-title":"Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients","volume":"50","author":"Zhang","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with COVID-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_50","first-page":"754","article-title":"Frequency and clinical correlates of antiphospholipid antibodies arising in patients with sars-cov-2 infection: Findings from a multicentre study on 122 cases","volume":"38","author":"Gatto","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type i interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Bhattacharjee, S., and Banerjee, M. (2020). Immune thrombocytopenia secondary to COVID-19: A systematic review. SN Compr. Clin. Med., 1\u201311.","DOI":"10.1007\/s42399-020-00521-8"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/bjh.16850","article-title":"COVID-19-associated immune thrombocytopenia","volume":"190","author":"Bomhof","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1056\/NEJMc2010472","article-title":"Immune thrombocytopenic purpura in a patient with COVID-19","volume":"382","author":"Zulfiqar","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e238039","DOI":"10.1136\/bcr-2020-238039","article-title":"Leucocytoclastic vasculitis in a patient with COVID-19 with positive sars-cov-2 pcr in skin biopsy","volume":"13","author":"Ferrer","year":"2020","journal-title":"BMJ Case Rep. CP"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Oda, R., Inagaki, T., Ishikane, M., Hotta, M., Shimomura, A., Sato, M., Nakamoto, T., Akiyama, Y., Yamamoto, K., and Minamimoto, R. (2020). Case of adult large vessel vasculitis after sars-cov-2 infection. Ann. Rheum. Dis.","DOI":"10.1136\/annrheumdis-2020-218440"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after chadox1 ncov-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after chadox1 ncov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/jth.15352","article-title":"An observational study to identify the prevalence of thrombocytopenia and anti-pf4\/polyanion antibodies in norwegian health care workers after COVID-19 vaccination","volume":"19","author":"Horvei","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2021012217","article-title":"Frequency of positive anti-PF4\/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2","volume":"138","author":"Thiele","year":"2021","journal-title":"Blood"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"100041","DOI":"10.1016\/j.clinpr.2020.100041","article-title":"Cold agglutinin syndrome as a complication of COVID-19 in two cases","volume":"7","author":"Jensen","year":"2020","journal-title":"Clin. Infect. Pract."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1055\/s-0040-1715791","article-title":"COVID-19 and cold agglutinin hemolytic anemia","volume":"4","author":"Maslov","year":"2020","journal-title":"TH Open"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/bjh.16794","article-title":"Autoimmune haemolytic anaemia associated with COVID-19 infection","volume":"190","author":"Lazarian","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Patil, N.R., Herc, E.S., and Girgis, M. (2020). Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection. Hematol. Oncol. Stem Cell Ther.","DOI":"10.1016\/j.hemonc.2020.06.005"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain\u2013barr\u00e9 syndrome associated with sars-cov-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fneur.2020.00909","article-title":"COVID-19 and guillain-barr\u00e9 syndrome: A case report and review of literature","volume":"11","author":"Zito","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/ene.14473","article-title":"Miller-fisher syndrome after COVID-19: Neurochemical markers as an early sign of nervous system involvement","volume":"27","author":"Senel","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_71","first-page":"e601","article-title":"Miller fisher syndrome and polyneuritis cranialis in COVID-19","volume":"95","year":"2020","journal-title":"Neurology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13256-020-02582-8","article-title":"Systemic lupus erythematosus manifestation following COVID-19: A case report","volume":"15","author":"Zamani","year":"2021","journal-title":"J. Med. Case Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s10067-020-05310-1","article-title":"Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology","volume":"39","author":"Hundal","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"102377","DOI":"10.1016\/j.msard.2020.102377","article-title":"Multiple sclerosis following sars-cov-2 infection","volume":"45","author":"Palao","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"100299","DOI":"10.1016\/j.ensci.2020.100299","article-title":"A first presentation of multiple sclerosis with concurrent COVID-19 infection","volume":"22","author":"Moore","year":"2021","journal-title":"Eneurologicalsci"},{"key":"ref_76","first-page":"6682251","article-title":"Demyelinating changes alike to multiple sclerosis: A case report of rare manifestations of COVID-19","volume":"2020","author":"Yavari","year":"2020","journal-title":"Case Rep. Neurol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1016\/S2665-9913(21)00106-5","article-title":"Incident systemic rheumatic disease following COVID-19","volume":"3","author":"Hsu","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1542\/hpeds.2020-0123","article-title":"COVID-19 and kawasaki disease: Novel virus and novel case","volume":"10","author":"Jones","year":"2020","journal-title":"Hosp. Pediatr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fcvm.2020.00094","article-title":"Antibodies and immunity during kawasaki disease","volume":"7","author":"Hicar","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"m2094","DOI":"10.1136\/bmj.m2094","article-title":"Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in paris, france: Prospective observational study","volume":"369","author":"Toubiana","year":"2020","journal-title":"BMJ"},{"key":"ref_81","unstructured":"Organisation, W.H. (2021, June 19). Multisystem Inflammatory Syndrome in Children and Adolescents Temporally Related to COVID-19. Available online: https:\/\/www.who.int\/news-room\/commentaries\/detail\/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The immunology of multisystem inflammatory syndrome in children with COVID-19","volume":"183","author":"Consiglio","year":"2020","journal-title":"Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cell.2020.09.034","article-title":"Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (mis-c)","volume":"183","author":"Gruber","year":"2020","journal-title":"Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e63430","DOI":"10.7554\/eLife.63430","article-title":"Post-acute COVID-19 associated with evidence of bystander t-cell activation and a recurring antibiotic-resistant bacterial pneumonia","volume":"9","author":"Gregorova","year":"2020","journal-title":"Elife"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.immuni.2021.05.010","article-title":"Longitudinal analysis reveals that delayed bystander cd8+ t cell activation and early immune pathology distinguish severe COVID-19 from mild disease","volume":"54","author":"Bergamaschi","year":"2021","journal-title":"Immunity"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Kanduc, D. (2020). From anti-sars-cov-2 immune responses to COVID-19 via molecular mimicry. Antibodies, 9.","DOI":"10.3390\/antib9030033"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1111\/bjh.16883","article-title":"Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?","volume":"190","author":"Angileri","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12192-020-01148-3","article-title":"Human molecular chaperones share with sars-cov-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: Possible role of molecular mimicry in COVID-19","volume":"25","author":"Fucarino","year":"2020","journal-title":"Cell Stress Chaperones"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"108426","DOI":"10.1016\/j.clim.2020.108426","article-title":"On the molecular determinants of the sars-cov-2 attack","volume":"215","author":"Kanduc","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"102591","DOI":"10.1016\/j.autrev.2020.102591","article-title":"Molecular mimicry may explain multi-organ damage in COVID-19","volume":"19","author":"Angileri","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"102556","DOI":"10.1016\/j.autrev.2020.102556","article-title":"Molecular mimicry between sars-cov-2 and respiratory pacemaker neurons","volume":"19","author":"Lucchese","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"100051","DOI":"10.1016\/j.jtauto.2020.100051","article-title":"Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity","volume":"3","year":"2020","journal-title":"J. Transl. Autoimmun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","article-title":"COVID-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between sars-cov-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.3389\/fimmu.2020.617089","article-title":"Reaction of human monoclonal antibodies to sars-cov-2 proteins with tissue antigens: Implications for autoimmune diseases","volume":"11","author":"Vojdani","year":"2021","journal-title":"Front. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/16\/8965\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:47:47Z","timestamp":1760165267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/16\/8965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":95,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ijms22168965"],"URL":"https:\/\/doi.org\/10.3390\/ijms22168965","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]}}}